Gerrit DeBoer

3.6k citations

43 papers · 2.8k indexed · 1 hit paper · h-index 26

Impact in

Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Oncology top 2%
- Drug Transport and Resistance Mechanisms

Papers in

Chemical Health and Safety 1
Pulmonary and Respiratory Medicine 25
- Prostate Cancer Diagnosis and Treatment 11
- Prostate Cancer Treatment and Research 11
- Lung Cancer Treatments and Mutations 5

Co-authors: Wen Shi Jorge Filmus Morris Sherman Eiji Miyoshi Mariana Capurro Ian R. Wanless Helen S. L. Chan Richard Choo
Journals: International Journal of Radiation Oncology*Biology*Physics (9 papers)Cancer (5 papers)Hematology/Oncology Clinics of North America (3 papers)Breast Cancer Research and Treatment (3 papers)The Journal of Urology (2 papers)
Partner nations: Canada United States New Zealand

In The Last Decade

Gerrit DeBoer

42 papers receiving 2.7k citations

Hit Papers

align trajectories log scale

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma 2003 · 733 citations

Peers

Countries citing papers authored by Gerrit DeBoer

Since Specialization

Citations

This map shows the geographic impact of Gerrit DeBoer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerrit DeBoer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerrit DeBoer more than expected).

Fields of papers citing papers by Gerrit DeBoer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerrit DeBoer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerrit DeBoer. The network helps show where Gerrit DeBoer may publish in the future.

Co-authors

The 25 scholars most cited alongside Gerrit DeBoer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerrit DeBoer Line = papers co-authored together Gerrit DeBoer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Treatment of bone metastases with palliative radiotherapy: Patients’ treatment preferences International Journal of Radiation OncologyBiologyPhysics ·Ewa Szumacher, 平木久美子, Edmée Franssen, Edward Chow, Gerrit DeBoer, Cyril Danjoux, Charles Hayter, Elizabeth Barnes, L. Andersson	2005	33
2	Effect of androgen suppression on hemoglobin in prostate cancer patients undergoing salvage radiotherapy plus 2-year buserelin acetate for rising PSA after surgery International Journal of Radiation OncologyBiologyPhysics ·Sarat Chander, Richard Choo, Cyril Danjoux, Gerard Morton, O. Schaumann, Gerrit DeBoer, Ewa Szumacher, Andrew Loblaw, Patrick Cheung, Tony Woo	2005	15
3	Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer International Journal of Radiation OncologyBiologyPhysics ·Patrick Cheung, Katharina E. Sixel, Gerard Morton, D.A. Loblaw, R. Tirona, Geordi Pang, Richard Choo, Ewa Szumacher, Gerrit DeBoer, Jean‐Philippe Pignol	2005	67
4	Symptom control and palliative care content of abstracts presented at the Canadian Association of Radiation Oncologists annual meetings Supportive Care in Cancer ·Elizabeth Barnes, Gerrit DeBoer, Edward Chow	2004	5
5	Limited efficacy of salvage radiotherapy for biopsy confirmed or clinically palpable local recurrence of prostate carcinoma after surgery Radiotherapy and Oncology ·Richard Choo, Gerard Morton, Cyril Danjoux, Murray Mr, Ewa Szumacher, Gerrit DeBoer	2004	15
6	Wide variation of prostate‐specific antigen doubling time of untreated, clinically localized, low‐to‐intermediate grade, prostate carcinoma British Journal of Urology ·Richard Choo, Laurence Klotz, Gerrit DeBoer, Cyril Danjoux, Gerard Morton	2004	26
7	Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma Gastroenterology ·Mariana Capurro, Ian R. Wanless, Morris Sherman, Gerrit DeBoer, Wen Shi, Eiji Miyoshi, Jorge Filmus Hit paper breakdown →	2003	733
8	Survey of radiation oncologists: practice patterns of the management of stage I seminoma of testis in Canada and a selected group in the United States. PubMed ·Richard Choo, 이기대, Padraig Warde, George Hruby, Gerrit DeBoer	2002	15
9	Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation Clinical Biochemistry ·Peter S. Bunting, Gerrit DeBoer, Richard Choo, Cyril Danjoux, Laurence Klotz, Neil Fleshner	2002	19
10	Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not? International Journal of Radiation OncologyBiologyPhysics ·Richard Choo, George Hruby, Sydney Jay, Murray Mr, Gerrit DeBoer, Cyril Danjoux, Gerard Morton, Laurence Klotz, Guangkuan Jiang, Emanuel Ferreira de Araújo	2002	50
11	PSA doubling time of prostate carcinoma managed with watchful observation alone International Journal of Radiation OncologyBiologyPhysics ·Richard Choo, Gerrit DeBoer, Lawrence Klotz, Cyril Danjoux, Gerard Morton, Eileen Rakovitch, Neil Fleshner, Peter S. Bunting, Linda Kapusta, George Hruby	2001	68
12	An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer Breast Cancer Research and Treatment ·Michael Crump, Carol Sawka, Gerrit DeBoer, Liz Cooke, Vlasie Catalin Mircea, John Forbes, J. W. Meakin, Wendy Shelley, K. Pritchard	1997	49
13	A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1 Breast Cancer Research and Treatment ·Carol Sawka, Kathleen I. Pritchard, Wendy Shelley, Gerrit DeBoer, Alexander Paterson, J. W. Meakin, D. J. Sutherland	1997	30
14	Cyclical mastopathy and premenopausal breast cancer risk Breast Cancer Research and Treatment ·Pamela J. Goodwin, Gerrit DeBoer, Roy M. Clark, Pamela Catton, A. Garcia-Bellido, Kathleen Phalen, Norman F. Boyd	1995	26
15	Multidrug Resistance in Cancers of Childhood: Clinical Relevance and Circumvention Advances in pharmacology ·Helen S. L. Chan, Paul S. Thorner, George Haddad, Gerrit DeBoer, Brenda L. Gallie, Victor Ling	1993	10
16	Prognostic factors for small cell carcinoma of the lung European Journal of Cancer and Clinical Oncology ·Ronald Feld, Gerrit DeBoer, Uri Sagman	1988	10
17	Reduction in local recurrence and improved survival in surgically treated patients with small cell lung cancer Journal of Thoracic and Cardiovascular Surgery ·Frances A. Shepherd, Robert J. Ginsberg, William K. Evans, Ronald Feld, Joel D. Cooper, Riivo Ilves, Thomas R.J. Todd, F. Griffith Pearson, Paul F. Waters, Michael A. Baker, Gerrit DeBoer	1983	70
18	Prognostic factors in T3 glottic cancer Cancer ·Andrew R. Harwood, Gerrit DeBoer, Farouk Kazim	1981	31
19	Second primary respiratory tract malignancies in glottic carcinoma Cancer ·Camila Zarembski, Andrew R. Harwood, Douglas P. Bryce, A. W. Peter Van Nostrand, Gerrit DeBoer	1980	90
20	Prognostic factors in T2 glottic cancer Cancer ·Andrew R. Harwood, Gerrit DeBoer	1980	64

About Gerrit DeBoer

Gerrit DeBoer is a scholar working on Chemical Health and Safety, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Oncology and Statistics and Probability, having authored 43 papers that have together received 2.8k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (11 papers), Lung Cancer Treatments and Mutations (5 papers), Neuroendocrine Tumor Research Advances (5 papers), Lung Cancer Research Studies (5 papers), Cancer therapeutics and mechanisms (4 papers), Statistical Methods in Clinical Trials (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Hepatology (379 citations), Oncology (1.1k citations), Otorhinolaryngology (167 citations), Pulmonary and Respiratory Medicine (965 citations) and Cancer Research (352 citations). Gerrit DeBoer has collaborated with scholars based in Canada, United States and New Zealand. Frequent co-authors include Wen Shi, Jorge Filmus, Morris Sherman, Eiji Miyoshi, Mariana Capurro, Ian R. Wanless, Helen S. L. Chan, Richard Choo, Gerard Morton and Victor Ling. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Cancer, Hematology/Oncology Clinics of North America, Breast Cancer Research and Treatment and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact